XII. 2. Seasonal Allergies

Hay fever and allergic rhinitis often trace back to low microbial diversity in the gut, which weakens immune tolerance.

An Immune Overreaction Influenced by Gut Microbial Diversity

Allergic responses to environmental allergens are not just immune malfunctions – they’re often signs of a dysbiotic gut failing to regulate immune tolerance [257] [264].

The relationship between gut microbiota and allergic airway disease was established through the seminal germ-free^[G] animal experiments: germ-free mice develop exaggerated IgE responses to allergens and show hyperreactive Th2 immune profiles that normalize with colonization. The clinical translation came through birth cohort studies showing that gut microbiota composition in the first year of life predicted atopic sensitization and allergic disease at ages 5-7 in multiple independent cohorts. [257] A study by Fujimura and colleagues published in Nature Medicine in 2016 used samples from the CANUE/CHILD study to show that specific gut microbiota composition patterns at 3 months predicted subsequent wheeze and atopic sensitization. Infants with lower gut Lachnospiraceae, Veillonellaceae, and Peptostreptococcaceae abundance – the microbiota pattern associated with farm exposure in other cohorts – had higher subsequent allergic disease rates. When nasal lavage and stool samples from these infants were used to colonize germ-free mice, the mice with the dysbiotic infant microbiota showed increased airway hyperresponsiveness upon house dust mite challenge. [297] Seasonal allergies (pollinosis) specifically show gut microbiota associations mediated through the immune cross-regulation pathway: the gut microbiota shapes the magnitude and threshold of IgE production and mast cell reactivity that determines allergic response intensity. Higher gut microbial diversity and Prevotella and Faecalibacterium abundance have been associated with lower seasonal allergy severity in observational cohorts. [264] Probiotic trials in seasonal allergy have shown variable results, with some strains (Lactobacillus gasseri, Lactobacillus rhamnosus) reducing symptom scores and antihistamine use in pollen season, while others show no effect – underscoring the importance of strain specificity and the timing of intervention relative to pollen season.

The connection between gut microbiota and allergic disease became tractable through research on the "atopic march" – the developmental progression from infantile eczema through food allergy, asthma, and seasonal allergic rhinitis that characterizes the natural history of atopy in a substantial proportion of affected individuals. Epidemiological studies consistently found that the presence of early-life gut microbiota dysbiosis preceded and predicted later atopic sensitization. [257] A pivotal mechanistic study by Olszak and colleagues published in Science in 2012 showed that the timing of microbial exposure was critical for allergen sensitization: germ-free mice exposed to microbial colonization in the neonatal period developed normal immune responses to allergens, while germ-free mice that remained germ-free through the neonatal window and were colonized later showed persistent hypersensitivity to inhaled allergens in adulthood. The implication was that there is a critical developmental window during which microbial exposure sets the immune regulatory baseline, and that colonization after this window cannot fully correct the deficit. [297] The specific gut microbiota taxa associated with protection from seasonal allergic disease were identified in prospective cohort studies. Reduced abundance of Lactobacillus, Bifidobacterium, and Faecalibacterium prausnitzii in the first year of life was prospectively associated with higher risk of atopic sensitization by age 5. Butyrate-producing organisms and those that stimulate regulatory T cell (immune cells that suppress inflammation and promote tolerance) (immune cells that suppress excessive immune responses and maintain tolerance) development showed the strongest protective associations. [264] For individuals with established seasonal allergies, gut microbiota-targeted interventions show modest but consistent effects on symptom burden in randomized trials: probiotic supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus, and Bifidobacterium lactis reduced rhinitis symptom scores and nasal cytokine levels in seasonal allergic rhinitis patients during pollen season in controlled trials [39].

Allergic responses to environmental allergens arise not only from “immune mistakes” but from how the immune system has been trained over a lifetime. The gut microbiota is one of the major trainers of immune tolerance, continuously engaging with gut-associated lymphoid tissue and shaping how immune cells respond to both harmful pathogens and benign antigens. A well-regulated immune system typically distinguishes harmless substances—like pollen or house dust—from real threats; when this regulation falters, hypersensitive reactions become more likely [39].

Seasonal allergies, such as hay fever and allergic rhinitis, are mediated by IgE antibodies that signal mast cells and eosinophils to initiate inflammation. The rapid rise in these conditions in recent decades has paralleled changes in lifestyle, diet, and microbial exposures. Though genetics also contribute, emerging evidence shows that the gut microbiota is a central modulator of immune tolerance, influencing the balance between pro-inflammatory and regulatory pathways.

A diverse microbial community supports the development and function of regulatory T cells (Tregs), which help restrain excessive inflammatory responses. Microbial metabolites—including short-chain fatty acids produced from dietary fiber—are involved in signaling that encourages Treg differentiation and supports the production of anti-inflammatory cytokines such as IL-10. These effects help maintain a state of immune equilibrium where harmless antigens are tolerated rather than attacked.

Reduced microbial diversity, which has been observed in individuals at higher risk for allergic diseases, can weaken these regulatory networks. Observational studies link early alterations in the gut ecosystem with increased allergic sensitization, particularly when beneficial groups of bacteria are less abundant in infancy. Delayed maturation of microbial communities rich in fiber-fermenting bacteria correlates with a less robust Treg population and a higher likelihood of IgE-mediated allergy development later in childhood.

Lifestyle and environmental changes contribute to this pattern. Broad-spectrum antibiotic use, diets high in processed foods and low in fiber, urban living with limited contact with soil and animals, and reduced contact with environmental microbes in early life have all been associated with shifts in gut microbiota composition. These shifts are linked to immune dysregulation in ways that may predispose some individuals to allergic sensitization, though they act alongside genetic and other environmental factors.

Short-chain fatty acids are one mechanism by which microbiota influence distant organs. Animal studies demonstrate that elevated circulating SCFAs can modulate dendritic cell precursors in the bone marrow, altering immune cell behavior in the lungs and reducing allergic responses. While human data are less definitive, systematic reviews indicate associations between higher SCFA levels in early life and lower incidence of atopic conditions such as asthma or atopic dermatitis in childhood, though findings vary by age and disease type.

The concept once termed the “Hygiene Hypothesis” has evolved into a broader understanding that early-life exposure to a rich array of microbial signals supports immune maturation. Rather than implying that cleanliness itself causes allergies, more recent work emphasizes the role of environmental and microbial biodiversity in shaping tolerance pathways. Factors such as household pets, farm exposure, and diverse diets influence microbial colonization and immune programming in ways that may reduce allergic risk over time.

In clinical practice, these insights suggest that allergic symptoms reflect a complex interplay between genetics, immune development, and microbial ecosystems. While the microbiota is not the sole cause of allergies, it sets thresholds for immune reactivity and interacts with other systems such as epithelial barrier function and mucosal immunity. Supporting microbial diversity—especially in early life through balanced nutrition, judicious antibiotic use, and environmental exposures—can be one component of a comprehensive strategy to promote immune tolerance and reduce the severity of allergic reactions.

How to Support Microbiota for Allergy Modulation

A thoughtful approach to allergy care begins with daily dietary structure, emphasizing natural sources of fermentable fibers that nourish SCFA-producing microbes rather than relying on isolated supplements.

Traditionally fermented foods such as kefir, yogurt, or sauerkraut can be seen as gentle microbial educators, providing metabolic signals that may support mucosal immune balance when tolerated.

Regular contact with outdoor environments—gardens, forests, open fields—offers broad microbial biodiversity, an element increasingly recognized as relevant for immune maturation.

Moderate physical activity, often described as Zone 2 movement, supports gut motility and metabolic stability, factors that indirectly influence microbial communities.

Careful consideration of medication use, particularly antibiotics, is part of prevention; avoiding unnecessary courses helps preserve microbial continuity before high-exposure seasons.

Psychological well-being interacts with gut function through neuroendocrine pathways; habits that stabilize the stress response can therefore have secondary benefits for the gut–immune dialogue.

Foods rich in polyphenols—berries, green tea, colorful vegetables—act as microbial substrates and signaling molecules, complementing fiber-based strategies.

Probiotics may be useful in selected situations, yet their effects are product- and person-specific, best integrated after professional assessment rather than as universal solutions.

Regular sleep patterns help align host circadian rhythms with microbial activity, underscoring the role of temporal consistency in immune regulation.

Collaboration between patient and clinician allows these elements to be adapted to individual allergy patterns and sensitivities, forming a coherent rather than fragmented plan.

Microbiota Effects

• Lower gut microbial diversity is associated with reduced immune tolerance, but allergic sensitization results from multiple factors; microbiota acts as a modifier rather than a single cause; [297] [297]
• SCFA-producing bacteria (e.g., Faecalibacterium, Roseburia, certain Bifidobacterium) support Treg-mediated regulation, yet clinical effects depend on fiber intake, host genetics, and timing of exposure; [264] [264]
• Contact with environmental microbes from soil, plants, and animals can enrich microbial signals, though the benefit reflects overall biodiversity exposure rather than specific organisms;
• Evidence for individual probiotic strains in allergy is heterogeneous and context-dependent; results cannot be generalized from one product or population to another;
• Psychological stress alters gut motility and secretory IgA, creating functional dysbiosis that may amplify Th2-skewed responses without directly causing allergy;
• Data linking Veillonella expansion to exercise derive mainly from athletic settings; its relevance for allergic disease remains hypothetical;
• Dietary polyphenols act as microbial substrates and immune modulators, but their effects vary with microbial conversion capacity;
• Higher fiber intake tends to increase SCFA production and epithelial resilience; however, barrier function is influenced by many non-microbial factors as well;
• Antibiotic exposure, particularly in early life, is a reproducible risk modifier for allergic disease, yet magnitude depends on class, duration, and baseline microbiota;
• Circadian disruption can modify microbial rhythms and mucosal immunity, but its role in seasonal allergies is supportive rather than primary;
• Beyond bacteria, fungal (mycobiome), viral (virome), and archaeal communities participate in immune education; current diagnostics detect them imperfectly, limiting clinical targeting;
• Microbiota changes are measured by 16S rRNA, shotgun metagenomics, and metabolomics; none alone predicts allergy with sufficient accuracy for routine individual diagnosis.

Patient Guidance

• Try to base most meals on natural fiber sources such as vegetables, legumes, oats, and whole grains rather than special supplements.
• Add a small portion of fermented food (yogurt, kefir, sauerkraut) several times a week if you tolerate them well.
• Spend regular time outdoors—gardens, parks, forests—to benefit from everyday environmental biodiversity.
• Aim for moderate movement on most days, like brisk walking or cycling, at a pace where you can still talk.
• Use antibiotics only when clearly necessary and discuss timing with your doctor before heavy allergy seasons.
• Keep stress simple and manageable with short breathing breaks, gentle stretching, or daily routines you enjoy.
• Choose foods rich in natural plant compounds—berries, vegetables, green tea—more often than highly processed snacks.
• Consider probiotics only after medical advice; effects are individual and product-specific, not universal.
• Protect your sleep rhythm by keeping regular bedtimes and wake times, aiming for about 7–8 hours.
• Plan your allergy care together with your doctor, combining medication with lifestyle steps that support your gut.

References

[39] Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016. Link

Mechanistic review of short-chain fatty acids (SCFAs) — a major class of bacterial metabolites derived from dietary fibre fermentation — as central mediators between diet, gut microbiota, and host physiology. SCFAs activate G-protein-coupled receptors, inhibit histone deacetylases, and serve as energy substrates, thereby influencing metabolic, immune, and epigenetic processes. The authors synthesize evidence implicating SCFA-mediated signalling in both health maintenance and disease pathogenesis. Provides the conceptual backbone for fibre-based and microbiome-directed therapeutic strategies.

[257] Rook, G. A. Regulation of the immune system by biodiversity from the natural environment. Proc Natl Acad Sci USA. 2013. Link

This review summarizes evidence that proximity to natural environments associates with reduced mortality, cardiovascular disease and psychiatric morbidity. The authors highlight that rising chronic illness in high-income countries is associated with failing immunoregulation and persistent low-grade inflammation, partly attributable to lost exposure to evolutionarily co-adapted Old Friends microorganisms. The hypothesis links biodiversity-rich environments to immunoregulatory training that protects against chronic inflammatory disease. The findings reframe green-space exposure as immunological rather than purely psychological intervention.

[264] von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy. Nat Rev Immunol. 2010. Link

This review summarizes consistent epidemiological evidence that traditional farm upbringing protects children from asthma, hay fever and allergic sensitization. Early-life contact with livestock and fodder, and consumption of unprocessed cow's milk, are identified as the most effective protective exposures. Mechanistic studies point to activation and modulation of innate and adaptive immune responses through intense microbial exposure, including xenogeneic signals received prenatally or shortly after birth. The findings support farm-derived microbial exposures as a basis for allergy-prevention strategies.

[297] Fujimura KE, Sitarik AR, Havstad S et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016. Link

This US birth cohort study used 16S rRNA sequencing on 298 stool samples (age 1-11 months) to identify three neonatal gut microbiota composition states (NGM1-3) associated with different relative risks (RR) of multisensitized atopy at age 2 and physician-diagnosed asthma at age 4. The highest-risk NGM3 group showed lower Bifidobacterium, Akkermansia and Faecalibacterium, higher Candida and Rhodotorula and a pro-inflammatory metabolome. NGM3 faecal water ex vivo increased IL-4+ CD4+ T cells and reduced CD4+CD25+FOXP3+ Tregs; 12,13-DiHOME enrichment in NGM3 recapitulated this. The findings identify a microbially-derived metabolite causally linked to childhood atopy and asthma risk.